The novel JNK inhibitor AS602801 inhibits cancer stem cells <i>in vitro</i> and <i>in vivo</i>Masashi Okada, Chifumi Kitanaka, Kenta Kuramoto et al.|Oncotarget|2016Cited by 60
GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells.Hirotsugu Sakaki, Chifumi Kitanaka, Masashi Okada et al.|PubMed|2015Cited by 55
Aripiprazole, an Antipsychotic and Partial Dopamine Agonist, Inhibits Cancer Stem Cells and Reverses ChemoresistanceShuhei Suzuki, Chifumi Kitanaka, Masashi Okada et al.|Anticancer Research|2016Cited by 54
Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic AgentsTomomi Sanomachi, Chifumi Kitanaka, Shuhei Suzuki et al.|Anticancer Research|2017Cited by 39
Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson’s disease, as an anti-cancer stem cell drugMasashi Okada, Chifumi Kitanaka, Hiroyuki Takeda et al.|Oncotarget|2017Cited by 38